Last updated on February 2019

Trident II Tritanium Acetabular Shell Outcomes Study

Brief description of study

The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.

Clinical Study Identifier: NCT02999009

Find a site near you

Start Over

Rothman Institute

Egg Harbor Township, NJ United States
  Connect »

Hopsital for Special Surgery

New York, NY United States
  Connect »

UNC Orthopaedics

Chapel Hill, NC United States
  Connect »

Hinsdale Orthopaedics

Westmont, IL United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.